Lexaria Bioscience Completes Final Dosing On Schedule With Human Pilot Study 7, GLP-1-H26-7, To Evaluate Two Oral DehydraTECH-Semaglutide Compositions Against Wegovy Over Five Weeks
Benzinga Newsdesk 1 day ago
News
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Final visits were completed this week by all Study participants within all Study arms. With dosing complete and final blood samples taken, the Study work will now shift to laboratory sample analyses, quality control and review of all data, and then reporting.
No information from the Study will be provided to any third parties until all data has been reviewed and quality controlled. Lexaria will provide further information once that has been achieved.
